The TRIUMF community would like to share a warm welcome for the lab’s next Director, Dr. Nigel Smith, whose 5-year term as TRIUMF Director begins today.
The first of two hot cells to be installed in TRIUMF’sARIEL (Advanced Rare Isotope Laboratory)has begun factory acceptance testing, marking a critical milestone for ARIEL design and engineering teams.
TRIUMF, UBC, and the wider contingent of researchers have leveraged a one-of-a-kind, made-in-Canada laser to achieve world’s first manipulation and cooling of antimatter by laser.
Discover Our Lab is an accessible, curiosity-driven websitethat allows visitors to explore TRIUMF’s diverse science programs, delve into the lab’s 50+ year journey, and accessa full (and growing!) suiteof existing multimedia outreach content.
TRIUMF is entering the final stages of its effort to move from a joint venture to an incorporated non-profit with charitable status. On March 5, 2021, the TRIUMF Board of Management confirmed its intention that this process should be completed by June 1, 2021.
Innovate BC has announced $300,000 in funding through the Ignite program for TRIUMF and ARTMS to further develop and validate the production of zirconium-89 (Zr-89) for use in PET imaging scans for cancer patients eligible for immuno-oncology (IO) therapies.
